Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 3/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.54 |
| ▸ | ATM | Q13315 | 1/20 | 0.50 |
| ▸ | IL2 | P60568 | 2/20 | 0.49 |
| ▸ | USP2 | O75604 | 1/20 | 0.49 |
| ▸ | MAPT | P10636 | 1/20 | 0.49 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.49 |
| ▸ | TRPA1 | O75762 | 3/20 | 0.46 |
| ▸ | TLR7 | Q9NYK1 | 2/20 | 0.46 |
| ▸ | KIF11 | P52732 | 1/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.45 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.45 |
| ▸ | P2RY1 | P47900 | 2/20 | 0.43 |
| ▸ | GAA | P10253 | 1/20 | 0.43 |
| ▸ | TLR8 | Q9NR97 | 2/20 | 0.42 |
| ▸ | IGF1R | P08069 | 1/20 | 0.42 |
| ▸ | GRIK1 | P39086 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29608194 | 1.00 | MEN1 (0.54) | MEN1KMT2AATMIL2USP2 | |
| SCHEMBL10606310 | 0.90 | MEN1 (0.52) | MEN1KMT2AATMIL2USP2 | |
| SCHEMBL9728803 | 0.90 | MEN1 (0.52) | MEN1KMT2AATMIL2USP2 | |
| SCHEMBL9729612 | 0.89 | KIF11 (0.46) | MEN1KMT2AKIF11CYP1A2TRPV1 | |
| SCHEMBL9728378 | 0.87 | MEN1 (0.50) | MEN1KMT2AATMIL2USP2 | |
| SCHEMBL9504696 | 0.83 | MEN1 (0.49) | MEN1KMT2AATMIL2USP2 | |
| SCHEMBL8657856 | 0.83 | KMT2A (0.59) | MEN1KMT2AATMMAPTGAA | |
| Flufenoxuron SCHEMBL27798 | 0.83 | MEN1 (0.52) | MEN1KMT2AIL2USP2MAPT | |
| SCHEMBL31499167 | 0.83 | TLR8 (0.51) | MEN1KMT2AIL2USP2MAPT | |
| SCHEMBL8623087 | 0.83 | MEN1 (0.49) | MEN1KMT2AATMIL2USP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 340 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9949953-B2 | Topical compositions comprising fipronil and permethrin and methods of use | MERIAL INC. (US) | 2018-04-24 | — | — | US | claimed |
| US-20160361297-A1 | Topical Compositions Comprising Fipronil and Permethrin and Methods of Use | MERIAL, INC. (US) | 2016-12-15 | — | — | US | claimed |
| US-9066515-B2 | Topical formulations comprising 1-N-arylpyrazole derivatives and amitraz | MERIAL, INC. (US) | 2015-06-30 | — | — | US | claimed |
| US-20140024693-A1 | TOPICAL COMPOSITION | KEYBANK NATIONAL ASSOCIATION, AS COLLATERAL AGENT | 2014-01-23 | — | — | US | claimed |
| US-20130065930-A1 | TOPICAL COMPOSITION | OMNIPHARM LIMITED (GB) | 2013-03-14 | — | — | US | claimed |
| US-20130023490-A1 | TOPICAL FORMULATIONS COMPRISING 1-N-ARYLPYRAZOLE DERIVATIVES AND AMITRAZ | MERIAL, INC. | 2013-01-24 | — | — | US | claimed |
| EP-2395842-A2 | TOPICAL COMPOSITION | CIPLA LIMITED (IN) | 2011-12-21 | — | — | EP | claimed |
| WO-2010092355-A2 | TOPICAL COMPOSITION | CIPLA LIMITED (IN) | 2010-08-19 | — | — | WO | claimed |
| US-20020090387-A1 | Insecticidal combination to control mammal fleas in particular fleas in particular fleas on cats and dogs | JEANNIN PHILIPPE (FR) | 2002-07-11 | — | — | US | claimed |
| US-6096329-A | Insecticidal combination to control mammal fleas, in particular fleas on cats and dogs | MERIAL (FR) | 2000-08-01 | — | — | US | claimed |
| US-5567429-A | PESTICIDES COMPRISING AT LEAST ONE INSECT GROWTH REGULATOR POLYFLUOROPHENYL-ACYLUREA COMPOUND | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1996-10-22 | — | — | US | claimed |
| US-5300293-A | Mixture of antigrowth agent and dextrin | SUMITOMO CHEMICAL CO., LTD. (JP) | 1994-04-05 | — | — | US | claimed |
| US-5096710-A | Cockroaches, juvenile hormone or chitin synthesis inhibitor, dextrin, plant oil | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1992-03-17 | — | — | US | claimed |
| US-4782090-A | Benzoyl(thio)urea pesticides | BAYER AKTIENGESELLSCHAFT (DE) | 1988-11-01 | — | — | US | claimed |
| JP-7187924-A | — | — | None | — | — | JP | disclosed |
| US-20250331520-A1 | HARMFUL ORGANISM CONTROL COMPOSITION | NIPPON SODA CO., LTD. (JP) | 2025-10-30 | — | — | US | disclosed |
| CN-112996788-B | Anthelmintic heterocyclic compounds | 勃林格殷格翰动物保健美国公司 | 2024-07-16 | — | — | CN | disclosed |
| EP-0246061-B1 | A BENZOYLUREA DERIVATIVE AND ITS PRODUCTION AND USE | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1992-03-18 | — | — | EP | disclosed |
| EP-0431468-A1 | A poison bait for control for harmful insects | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1991-06-12 | — | — | EP | disclosed |
| US-4782090-A | Benzoyl(thio)urea pesticides | BAYER AKTIENGESELLSCHAFT (DE) | 1988-11-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130023490-A1 | TOPICAL FORMULATIONS COMPRISING 1-N-ARYLPYRAZOLE DERIVATIVES AND AMITRAZ | MGAT2, MGAT1, MIF | MEN1 3974/4885KMT2A 2162/4885ATM 3057/4885 |
| US-20160361297-A1 | Topical Compositions Comprising Fipronil and Permethrin and Methods of Use | FASN, MTPN, FAAH | MEN1 2044/4885KMT2A 2383/4885ATM 4537/4885 |
| US-20250331520-A1 | HARMFUL ORGANISM CONTROL COMPOSITION | OLA1, SOD1, GLB1 | MEN1 676/4885KMT2A 1739/4885ATM 3424/4885 |
| US-20020090387-A1 | Insecticidal combination to control mammal fleas in particular fleas in particular fleas on cats and dogs | CUTA, IGF1R, FIBP | MEN1 2712/4885KMT2A 2650/4885ATM 4462/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.